Skip to content

Clinical trials

Phase 2 Margins of Excision trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Margins of Excision Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20142
20181
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Associació per a la Recerca Oncologica, Spain1
Ayal A. Aizer, MD1
Indonesia University1
Jules Bordet Institute1
Medical University of South Carolina1
Northwestern University1
Novartis Pharmaceuticals1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Margins of Excision9
Breast Neoplasms2
Carcinoma, Renal Cell2
Neoplasms2
Adenocarcinoma1
Brain Neoplasms1
Carcinoma1
Carcinoma, Hepatocellular1
Head and Neck Neoplasms1
Liver Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.